How has Veracyte's lessee operating lease liability payments due changed year-over-year?

Veracyte's lessee operating lease liability payments due decreased by 23.4% year-over-year, from $93.22M to $71.44M.

Veracyte VCYT Lessee Operating Lease Liability Payments Due

Lessee Operating Lease Liability Payments Due at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

Bio-Rad LaboratoriesBIO

——

Idexx LaboratoriesIDXX

——

AbbottABT

——

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's lessee operating lease liability payments due.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's lessee operating lease liability payments due?: Veracyte (VCYT) reported lessee operating lease liability payments due of $71.44M in Q1 2026.
How has Veracyte's lessee operating lease liability payments due changed year-over-year?: Veracyte's lessee operating lease liability payments due decreased by 23.4% year-over-year, from $93.22M to $71.44M.